Metabolic consequences of bone turnover in Paget's disease of bone
- PMID: 3549093
Metabolic consequences of bone turnover in Paget's disease of bone
Abstract
High rates of bone resorption, bone formation, and marrow fibrosis are characteristic of Paget's disease of bone. This excessive bone turnover is reflected by increased fluxes of calcium ions out of and into the skeleton. The rates of these fluxes are highly geared to each other such that calcium balances are close to zero in the absence of fracture or significant immobilization. An increased turnover of bone matrix is also evident by increased urinary excretion of collagen breakdown products (oligopeptides of hydroxyproline, hydroxylysine, and hydroxylysine glycosides) as well as products (peptides of higher molecular weight) related to collagen synthesis. Increased circulatory levels of procollagen extension fragments reflect increased synthesis of Type I collagen (bone matrix) and Type III collagen (marrow fibrosis). Increased levels of bone gamma-carboxyglutamic acid-protein presumably reflect primarily bone matrix synthesis but bone resorption as well. When bone resorption is suppressed pharmacologically, the abnormal levels of these markers of matrix turnover and osteoblastic activity (alkaline phosphatase) also decrease, presumably as a result of coupling of resorption and formation.
Similar articles
-
Skeletal metabolism in Paget's disease of bone.Arthritis Rheum. 1980 Oct;23(10):1087-94. doi: 10.1002/art.1780231004. Arthritis Rheum. 1980. PMID: 7000079 Review.
-
Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.J Clin Invest. 1977 May;59(5):819-27. doi: 10.1172/JCI108704. J Clin Invest. 1977. PMID: 404321 Free PMC article.
-
Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.Arthritis Rheum. 1998 Feb;41(2):354-60. doi: 10.1002/1529-0131(199802)41:2<354::AID-ART20>3.0.CO;2-5. Arthritis Rheum. 1998. PMID: 9485094 Clinical Trial.
-
Paget's disease of bone.Clin Orthop Relat Res. 1977;(127):24-36. Clin Orthop Relat Res. 1977. PMID: 410574 Review. No abstract available.
-
Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.J Bone Miner Res. 1997 Sep;12(9):1407-15. doi: 10.1359/jbmr.1997.12.9.1407. J Bone Miner Res. 1997. PMID: 9286756
Cited by
-
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.J Clin Invest. 1992 Jan;89(1):46-52. doi: 10.1172/JCI115584. J Clin Invest. 1992. PMID: 1729280 Free PMC article.
-
Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease.J Clin Invest. 1990 Apr;85(4):1280-6. doi: 10.1172/JCI114565. J Clin Invest. 1990. PMID: 2318982 Free PMC article.
-
Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.J Bone Miner Res. 2014 Jun;29(6):1456-65. doi: 10.1002/jbmr.2158. J Bone Miner Res. 2014. PMID: 24339057 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical